Scientists engineer the photosynthetic bacteria spirulina to produce biologics at a large enough scale to treat some of the world’s deadliest and most prevalent diseases.
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.